|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
EP0841396B2
(en)
*
|
1996-10-01 |
2012-04-11 |
Geron Corporation |
Human telomerase catalytic subunit
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
CA2347067C
(en)
|
1998-03-31 |
2013-09-17 |
Geron Corporation |
Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
*
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
WO2002070748A2
(en)
*
|
2000-10-24 |
2002-09-12 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
AU2002240197A1
(en)
*
|
2001-02-01 |
2002-08-12 |
Tanox, Inc. |
Methods to generate and identify monoclonal antibodies to a large number of human antigens
|
|
DE10112851C1
(de)
*
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
EP1390076A4
(en)
*
|
2001-04-27 |
2004-12-15 |
Xcyte Therapies Inc |
Maturation of antigen-presenting cells with activated cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
EP2842964A1
(de)
|
2001-06-05 |
2015-03-04 |
Curevac GmbH |
Virtuelles Verfahren zur Ermittlung einer modifzierten mRNA-Sequenz
|
|
WO2003023026A1
(en)
*
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
US20040086485A1
(en)
*
|
2001-10-04 |
2004-05-06 |
Aguilar-Cordova Carlos Estuardo |
Chemeric viral vectors for gene therapy
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CN1665523A
(zh)
*
|
2002-07-05 |
2005-09-07 |
杜克大学 |
血管免疫疗法
|
|
AU2003278709A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
DK2261249T3
(en)
|
2002-09-12 |
2015-02-16 |
Oncotherapy Science Inc |
KDR peptides and vaccines comprising the same
|
|
AU2003296439B2
(en)
*
|
2002-12-10 |
2009-05-07 |
Argos Therapeutics, Inc. |
In situ maturation of dendritic cells
|
|
ES2630222T3
(es)
*
|
2002-12-13 |
2017-08-18 |
Alphavax, Inc. |
Partículas alfavíricas y métodos de preparación
|
|
JP4991108B2
(ja)
|
2002-12-13 |
2012-08-01 |
アルファバックス，インコーポレイティド |
多抗原性アルファウイルス・レプリコン粒子及び方法
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
WO2004074451A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
EP2557164A1
(en)
|
2003-02-18 |
2013-02-13 |
Kevin M. Slawin |
Induced activation in dendritic cells
|
|
CN1791678A
(zh)
*
|
2003-03-20 |
2006-06-21 |
阿尔法瓦克斯公司 |
改进的甲病毒复制子和辅助构建体
|
|
PT1651666E
(pt)
*
|
2003-07-11 |
2009-08-28 |
Alphavax Inc |
Vacinas de citomegalovírus à base de alfavírus
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
CA2546378A1
(en)
*
|
2003-11-25 |
2005-06-09 |
Argos Therapeutics, Inc. |
Mrna transfected antigen presenting cells
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
JP2007528375A
(ja)
*
|
2004-03-02 |
2007-10-11 |
典也 大野 |
癌の治療および予防用雑種細胞ワクチンの方法および組成物
|
|
AU2005245956B2
(en)
*
|
2004-05-18 |
2011-05-19 |
Alphavax, Inc. |
TC-83-derived alphavirus vectors, particles and methods
|
|
WO2005116261A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Albert Einstein College Of Medecine Of Yeshiva University |
Rna expression microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
ES2610781T3
(es)
|
2004-09-14 |
2017-05-03 |
Argos Therapeutics, Inc. |
Amplificación de patógenos independiente de la cepa y vacunas para estos
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
EP1853703B1
(en)
|
2005-02-25 |
2011-04-13 |
Oncotherapy Science, Inc. |
Peptide vaccines for lung cancers expressing ttk polypeptides
|
|
ES2435650T3
(es)
|
2005-02-28 |
2013-12-20 |
Oncotherapy Science, Inc. |
Péptidos epítopos derivados del receptor 1 del factor de crecimiento endotelial vascular y vacunas que contienen estos péptidos
|
|
EP1882031B1
(en)
|
2005-04-08 |
2017-11-08 |
Argos Therapeutics, Inc. |
Dendritic cell compositions and methods
|
|
BRPI0613970B8
(pt)
|
2005-07-27 |
2021-05-25 |
Oncotherapy Science Inc |
composição para o tratamento ou para a prevenção de câncer de cólon compreende uma quantidade farmaceuticamente eficaz de um sirna contra um polinucleotídeo de tom 34
|
|
WO2007047764A2
(en)
|
2005-10-17 |
2007-04-26 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
EP3117836A1
(en)
|
2006-04-10 |
2017-01-18 |
Sloan Kettering Institute For Cancer Research |
Immunogenic wt-1 peptides and uses thereof
|
|
US20070281336A1
(en)
|
2006-04-14 |
2007-12-06 |
Epicentre Technologies |
Kits and methods for generating 5' capped RNA
|
|
CN101484461B
(zh)
|
2006-08-18 |
2014-09-17 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
BRPI0717651A2
(pt)
|
2006-10-17 |
2013-12-24 |
Oncotherapy Science Inc |
Vacinas de peptídeo para cânceres que expressam polipeptídeos mphosph1 ou depdc1
|
|
AU2007310946B2
(en)
*
|
2006-10-19 |
2014-06-05 |
Baylor College Of Medicine |
Generating an immune response by inducing CD40 and pattern recognition receptors
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI615403B
(zh)
|
2007-02-21 |
2018-02-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TWI434853B
(zh)
|
2007-04-11 |
2014-04-21 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
NZ582495A
(en)
*
|
2007-06-21 |
2012-05-25 |
Alphavax Inc |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
JP5555952B2
(ja)
|
2007-08-20 |
2014-07-23 |
オンコセラピー・サイエンス株式会社 |
Ｆｏｘｍ１ペプチドおよびこれを含む薬剤
|
|
EP2254998B1
(en)
*
|
2008-02-28 |
2015-12-23 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
CA2728739C
(en)
|
2008-06-20 |
2017-07-11 |
Duke University |
Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
|
|
DK2331680T3
(en)
|
2008-09-22 |
2017-08-21 |
Baylor College Medicine |
Methods and Compositions for Generating an Immune Response by Induction of CD-40 as well as Pattern Recognition Receptor Adapters
|
|
CA2743669C
(en)
|
2008-11-24 |
2018-10-16 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
High affinity t cell receptor and use thereof
|
|
TWI539160B
(zh)
|
2008-12-05 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
SG2014013148A
(en)
|
2009-03-18 |
2014-07-30 |
Oncotherapy Science Inc |
Neil3 peptides and vaccines including the same
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
KR101872284B1
(ko)
|
2010-03-11 |
2018-06-28 |
온코세라피 사이언스 가부시키가이샤 |
Ｈｊｕｒｐ 펩티드 및 이를 포함한 백신
|
|
TWI538685B
(zh)
|
2010-04-02 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK4108671T3
(da)
|
2010-10-01 |
2025-01-06 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer samt anvendelser deraf
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
JP5564730B2
(ja)
|
2011-08-12 |
2014-08-06 |
オンコセラピー・サイエンス株式会社 |
Ｍｐｈｏｓｐｈ１ペプチドおよびそれを含むワクチン
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
CN104066746B
(zh)
|
2011-10-28 |
2017-12-05 |
肿瘤疗法科学股份有限公司 |
Topk肽及包含它们的疫苗
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
HK1204261A1
(en)
|
2012-01-13 |
2015-11-13 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
EP2872530A4
(en)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
PT2945647T
(pt)
|
2013-01-15 |
2020-11-26 |
Memorial Sloan Kettering Cancer Center |
Péptidos imunogénicos wt-1 e métodos de uso dos mesmos
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
AU2014236726A1
(en)
|
2013-03-14 |
2015-09-17 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling T cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP6467406B2
(ja)
|
2013-06-05 |
2019-02-13 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
カスパーゼポリペプチドを使用して部分的なアポトーシスを誘導するための方法
|
|
EP3888675A1
(en)
|
2013-09-24 |
2021-10-06 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
JP6772063B2
(ja)
|
2014-02-14 |
2020-10-21 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
誘導可能なキメラポリペプチドを使用して細胞を活性化するための方法
|
|
US9610358B2
(en)
*
|
2014-04-17 |
2017-04-04 |
Marker Gene Technologies, Inc |
Targeted pharmacological chaperones
|
|
WO2016014613A1
(en)
*
|
2014-07-22 |
2016-01-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
EP3981416B1
(en)
|
2014-08-04 |
2024-03-20 |
OncoTherapy Science, Inc. |
Koc1-derived peptide and vaccine including same
|
|
SG10201900835XA
(en)
|
2014-08-04 |
2019-03-28 |
Oncotherapy Science Inc |
Urlc10-derived peptide and vaccine containing same
|
|
KR20170040315A
(ko)
|
2014-08-04 |
2017-04-12 |
온코세라피 사이언스 가부시키가이샤 |
Cdca1-유래 펩티드 및 이를 포함하는 백신
|
|
WO2016036746A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
MX383271B
(es)
*
|
2014-09-17 |
2025-03-13 |
Univ Johns Hopkins |
Reactivos y metodos para identificar, enriquecer y/o expandir celulas t especificas de antigeno.
|
|
KR102357004B1
(ko)
*
|
2014-10-27 |
2022-01-27 |
프레드 헛친슨 켄서 리서치 센터 |
입양 세포 면역요법의 효능을 강화하기 위한 조성물 및 방법
|
|
US10189880B2
(en)
|
2014-11-03 |
2019-01-29 |
Leiden University Medical Center |
T cell receptors directed against Bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
BR112018005581A2
(pt)
|
2015-10-08 |
2018-10-16 |
Oncotherapy Science, Inc. |
peptídeo derivado de foxm1 e vacina incluindo o mesmo
|
|
US11780934B2
(en)
|
2016-02-05 |
2023-10-10 |
Institut Pasteur |
Use of inhibitors of ADAM12 as adjuvants in tumor therapies
|
|
JP7033549B2
(ja)
|
2016-05-04 |
2022-03-10 |
フレッド ハッチンソン キャンサー リサーチ センター |
細胞に基づくネオ抗原ワクチンおよびその使用
|
|
EP3478073B1
(en)
*
|
2016-06-29 |
2025-11-26 |
Duke University |
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
|
|
EP3735264A1
(en)
*
|
2018-01-05 |
2020-11-11 |
Rolf Jonas Andreas Nilsson |
Endogenous tumor-derived circular rna and proteins thereof for use as vaccine
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
WO2025101584A1
(en)
*
|
2023-11-06 |
2025-05-15 |
Immunitybio, Inc. |
Virally educated t cells
|